Erlotinib 100mg qd Versus Gefitinib 250mg qd for EGFR Mutant Nsclc

Clinical trial NCT01955421 · UNKNOWN

Trial details

NCT number: NCT01955421
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Stage Non Small Cell Lung Cancer

Start date: 2013-07-01
Primary completion: 2016-06-01
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.